Tags Posts tagged with "buy marijuana stocks"

buy marijuana stocks

0 2189

Among the many segments of the marijuana industry that we cover, CBD has taken on a big role not only for its biotech-based applications but also for its uses outside of the health sciences sector. And with the growth that the market as a whole could be set to see, CBD companies are definitely in the spotlight for the foreseeable future.

One Marijuana Stock that we’ve been reporting on since late last year has been Ubiquitech Software Corp (UBQU).  Now don’t let the name fool you, this company, through its subsidiary HempLife Today™ is breaking barriers with its CBD brand while also hitting major milestones over the last year.  What could be best of all is that 2017 could already have the stage set for yet another record setting period in (UBQU)’s company history.

Earlier this morning the company put out preliminary guidance on what it is anticipating to be a banner year ahead.  According to the release, the company anticipates that revenues for the year ending November 30, 2017 will increase over 55% from $3,493,113, which was reported in the annual period ended November 30, 2016 to approximately $5,450,000.

Ubiquitech Gives Fiscal Year 2017 Revenue Guidance; Anticipates 55% Year Over Year Increase To $5,450,000

“We are very pleased with the progress we have made and we will continue to do everything within our power to keep our company relevant and growing” said James Ballas, CEO “With the quality of our products, our marketing, customer support and satisfaction, and our dynamic thinking, we will continue this growth through 2017 and into 2018, which we are already planning big things for, and this is the thinking that will take our revenues to even higher gains as we continue. It’s a very exciting industry and we don’t plan to stop until the CannazALL brand is a household word.”

(UBQU) is no stranger to growth.  If you’re just pulling up the company’s other headlines, you’ll already notice major strides being made on the product end. Toward the beginning of the year, the company announced that it had concluded negotiations and reached an agreement to expand its hemp growing capabilities through an additional 140 acres of available hemp operations. They’ve also expanded their current product line to include brand new offerings.

But back to growth…Had this been a random company with its first press release in history, we might be a bit skeptical but (UBQU) has already proven its ability to run a multi-million dollar business that has managed to grow significantly just within the last year alone. On top of bullish guidance for the year ahead, (UBQU) is also coming off of a strong year and noticeable earnings growth.

Revenues for the last quarter increased to $1,225,015 and to $3,493,113 for the year. But what’s more is that net income increased over 700% from the previous year to $334,350 from $39,651 in 2015. First quarter guidance has already come in bullish on its own with the company expecting revenues for the quarter ended February 28, 2017 to increase over 50% from $697,640 in the first quarter of last year to approximately $1,050,000.

Of course this is just initial guidance and with the year ahead, nothing is set in stone. But one thing is certain and that based on the last releases from the company, (UBQU) has set itself on a growth trend.  So this bullish guidance could be shedding some light on what’s to come for this company in the very near term.

The opportunity for taking advantage of the growth that CBD is beginning to see, could be important to take into consideration.  We’ve previously written about this market and how it could be on a path for growth.  Figures estimate that the CBD market will grow to a $2.1 billion market in sales by 2020. That’s a 700% increase from 2016.  Think about this for a moment: (UBQU) is already growing and is expecting to continue this growth to the tune of 50+% for the year according to today’s announcement…this is all going to happen during a time where the CBD industry as a whole is also anticipating significant growth. Having already come off of a banner year, we think that preliminary guidance from the company would suggest that this is something to be paying close attention to moving into the coming weeks/months/quarters.

Again, you can access today’s (UBQU) news here:

Ubiquitech Gives Fiscal Year 2017 Revenue Guidance; Anticipates 55% Year Over Year Increase To $5,450,000

Pursuant to an agreement between MAPH and Ubiquitech Software Corp., we were hired for a period beginning November 11 2016 and ending May 11, 2017 to publicly disseminate information about (UBQU) including on the Website and other media including Facebook and Twitter. We are being paid $0 (CASH) for or were paid “10 million” shares of restricted common shares. We may buy or sell additional shares of (UBQU) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Full Disclaimer Here

 

 

 

0 441

DENVER, CO–(Mar 23, 2017) – Ubiquitech Software Corp. ( OTC PINK : UBQU ), through its operating subsidiary HempLifeToday.com, is announcing fiscal year 2017 revenue guidance.

The company anticipates that revenues for the year ending November 30, 2017 will increase over 55% from $3,493,113 reported in the year ago period to approximately $5,450,000.

The company is basing this guidance on the strong internal first quarter numbers and the continuance of that trend during March of this year. The company continues to gain increased exposure of its HempLife Today product line, develop new and improved products, and spread the word regarding the benefits of CBD Hemp derived products available and sold through its proprietary CBD brand CannazALL.

The company expects to give updates on its full year guidance in the coming months. The company sells and markets its line of high quality products through its web portal www.HempLifeToday.com.

“We are very pleased with the progress we have made and we will continue to do everything within our power to keep our company relevant and growing,” said James Ballas, CEO. “With the quality of our products, our marketing, customer support and satisfaction, and our dynamic thinking, we will continue this growth through 2017 and into 2018, which we are already planning big things for, and this is the thinking that will take our revenues to even higher gains as we continue. It’s a very exciting industry and we don’t plan to stop until the CannazALL brand is a household word.”

“With the wide footprint we have on the Internet and the amount of industry content about us that is also growing, we have the ability to grow while also protecting revenue,” adds Tim Zorn, President. “This allows us to strategically spend advertising dollars where we get the best results and is why our cost per customer acquisition is down by over 90% since last year. Steady sales and profitability is what we always strive for.”

The Company wants shareholders to know that it is moving forward on all plans released in previous press from 3.09.2017. This update is to inform shareholders of company progress and to keep shareholders informed of said progress.

About Ubiquitech (HempLife Today™)
Ubiquitech Software Corp, through its subsidiaries is a dynamic multi-media, multi-faceted corporation utilizing state-of-the-art global internet marketing, Direct Response (DRTV) Television, Radio, and traditional marketing, to drive traffic to the new and emerging multi-billion dollar industries like its subsidiary HempLifeToday.com™

HempLifeToday™ focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life enriching enhancement that CBD Oil from the Hemp plant can bring. Through its network of quality USA growers HempLifeToday.com™ has developed multiple and proprietary CannazALL™ CBD oil products that include; It’s popular CBD Tinctures, Oils, GelCaps, CBD Powder, Skin Salve, Wax Crumble, and e-liquid, all offered @ www.HempLifeToday.com

This press release contains forward-looking statements. Words such as “expects”, “intends”, “believes”, and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, the ability to secure additional sources of finance, the ability to reduce operating expenses, and other factors described in the Company’s filings with the OTC Markets Group. The actual results that the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

0 3235
Marijuana Stocks

Marijuana Stocks, especially Cannabis Companies with strong ties to Biotech have been increasingly front and center on Wall Street’s main stage.  Marijuana Stocks and the Cannabis-Biotech sector continue to evolve and grow into the mainstream powerhouse we know it can and will be. We have identified a small Cannabis-Biotech start up that deserves your attention.

InMed Pharmaceuticals (IMLFF) is a Vancouver-based pre-clinical trial Cannabis-Biotech company that has not only developed a proprietary cannabinoid manufacturing system yet in the process created a highly sought after database, which has mapped the different compounds of cannabinoids to the various diseases that it can address.

This cannabinoid database was designed by (IMLFF) to assist them in their investigative studies and has currently become a core asset as other Cannabis Biotech companies have come knocking on their door willing to offer a hefty sum for this information. Most medical marijuana processors are using THC and CBD because they are easy to extract in large quantities, however there are more than 90 diverse cannabinoid structures that (IMLFF) has plugged into its system. The bioinformatics algorithm has taken those different compounds and screens them against approved drugs, diseases and genetic properties of diseases. It then selects specific cannabinoids that might help regulate that particular disease.

InMed Pharmaceuticals (IMLFF) has created this database “tool” & is saving time and money in the drug research process. It has already helped (IMLFF) to identify two treatments for rare diseases. One for a rare children’s skin disease called epidermolysis bullosa (EB) that has no approved treatments and the other for glaucoma. Chief Executive Officer Eric Adams said, “It’s a very devastating disease and we found out in early testing that this set of cannabinoids treat the major symptoms of this disease giving them a tremendous amount of relief, but it may also reverse the disease, which is something no one has really talked about before.”

Startup Cannabis-Biotechs like InMed Pharmaceuticals (IMLFF) will continue to grow as Marijuana Stocks / Sector continues to evolve into mainstream markets.

0 2319

Marijuana Stocks, Inauguration Day, & Trump’s Bump

Here we are, just after the official inauguration day of our 45th President of the United States of America, Donald Trump. A lot has been said about him over the last few years during the election race but what many may not have expected was a clear “Trump Bump” for marijuana stocks.


Click Here To View Full Article


 

Facts Regarding Denver’s New Marijuana In Public Law

Denver has begun working on the country’s first law allowing use in public places like coffee shops and cannabis clubs. However, the details about what those marijuana clubs would look like are still unclear. Here are some answers to questions about the cannabis clubs headed to Denver.


Click Here To View Full Article


 

Veterans In Support Of Medical Marijuana



Indiana American Legion reached an agreement on Sunday that would support a medical cannabis study to treat injuries to military service members, such as traumatic brain injuries and PTSD. The veteran service organization said they are working to urge Indiana legislators to approve the private growth and research of medicinal cannabis and to reclassify marijuana as a drug with potential medical value.


Click Here To View Article


 

 

 PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

3 23933

Today is the final trading day of the year will definitely be one that investors will always remember. The market remains in the positive as companies are better positioned for success. From the advance of the Canadian marijuana industry to election of Donald Trump, there will be a lot for investors to watch next year. We would like to highlight some themes anticipated to play out over 2017.

Consolidation

One of the brightest spots of the marijuana industry in 2016 was the Canadian licensed medical marijuana producer sub-sector. In early December, Mettrum Health (MT.V)(MQTRF) and Canopy Growth (CGC.TO)(TWMJF) announced an agreement where Canopy Growth will gain all of the outstanding shares of Mettrum.

Keep your eyes on the marijuana industry as it is expected to see more deals like this over the next year. The possibility for increase consolidation makes these companies attractive investment opportunities: Aphiria (APH.V)(APHQF), Supreme (SL.V)(SPRWF), OrganiGram (OGI.V)(ORGMF), Emblem Corporation (EMC.V), and Aurora Cannabis (ACB.V)(ACBFF).

Transformation

The biotech sector will be one of the greatest recipients of the legal marijuana movement and recent sector weakness has created opportunities for investors.
GW Pharmaceuticals (GWPH) reported its second Stage Three Clinical trial in September for its Epidiolex product for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS). We continue to view GWPH as one of the top marijuana investments due to its capability to convert the cannabis industry through the development of treatments for sickness’ that don’t currently have an approved regimen.

Execution

From the financial structure, investors need to conduct with earnestness. We suggest incorporating some guidelines into your investment blueprint.

To end 2016, we want to highlight some of the stocks investors should watch during next year: Emblem Corporation (EMC.V)(EMMBF), Zoned Properties (ZDPY), Aphria (APHQF), Kush Bottles (KSHB), American Cannabis (AMMJ), Aurora (ACBFF), Reliq Healthcare (RQHTF), Zynerba Pharmaceuticals (ZYNE), OrganiGram (OG.V)(ORGMF), Arcturus Grothstar Tech (AGSTF), MassRoots (MSRT), VPR Brands (VPRB), CV Sciences (CVSI), mCig (MCIG), Canopy Growth (TWMJF)(CGC.TO), Medicine Man Tech (MDCL), GW Pharmaceuticals (GWPH), Lexaria (LXRP), Canabo Medical (CMM.V)(CAMDF), Mettrum Health (MT.V), and VinergyRes (VIN.CN).

0 43284

One of the biggest questions we get on MarijuanaStocks.com is “How do I buy Marijuana Stocks?” First, we aren’t financial advisors, but we can offer you a good starting point and some relevant information. We get thousands of emails from our subscribers and created this based off of your inquiries. MarijuanaStocks.com hopes this is a helpful guide to potential investors interested in the Cannabis sector, but we encourage you to continue your research and hopefully you’ll become the next Pot Stock millionaire! Cheers

    0 2214

    Over recent weeks we’ve been shedding more light on the hemp industry and why we see it as an important part of the bigger cannabis space.  Marijuana Stocks, the Wolf of Weed Street and Cheryl Shuman have been working closely with FBEC Worldwide to help develop the first branded hemp infused energy drink for FBEC called the “Wolf Shot Hemp Energy.” The product launch is slated for August 1 and buzz has grown quickly.  Friday FBEC Worldwide was highlighted in an article on TheStreet.com, which focused specifically on the Hemp industry, what it is, why it’s important, and why investors should be paying much more attention to it now more than ever:

    “Hemp Won’t Get You High, But Could Boost Your Portfolio Sooner Than You Think”

    The article discusses the differences between hemp and marijuana citing that though they both are derived from the same type of cannabis plant, their uses couldn’t be more different. Major health benefits from hemp include higher levels of easily digestible protein, longer sustained levels of energy, improved mental focus and even reduction in cardiovascular disease.  The biggest benefit is that though it is limited to growing in the US, using and selling products that have it is not.  Highlighting FBEC Worldwide as a viable option for taking advantage of the growth that this space could see in both short and long terms adds much more legitimacy to the company and shows the true differences between companies planning to do something and companies actually doing it like FBEC Worldwide is; now 3 weeks away from initial product launch.

    Read the full article HERE

      3 9894

      There have been hundreds of marijuana stocks covered in the market, which have captivated the interest of investors. CannaGrow Holdings, Inc. (CGRW) in particular has seen a fair share of attention throughout 2014-2015. It stands to reason that this company has managed to gain momentum after announcing significant developments month over month over the last 3 quarters and has helped to strengthen CannaGrow in becoming a new leader within the industry. But why?

      Initiation and approval of the Colorado Buffalo Ranch project have been the major focal points for the company and over the course of the last 7 months, CannaGrow has acted as a consultant and liaison to NuGro Industries in order to build a leading position in the green house market for Colorado’s marijuana industry.

      The Future For Marijuana Cultivation: Green House Growing

      Conservatives certainly couldn’t have imagines a world where marijuana would be nearing universal legalization and though only 4 states have legalized recreational marijuana, half of the US and the District of Columbia have laws in place that allow medical marijuana to shine. States like New York and Illinois have singled out the drug to be used only by “smokeless” methods and the marijuana industry as a whole – outside of the medical space – has found that nearly have of the industry’s sales are coming by way of edibles.

      No longer is it a matter of “beautiful buds”. Now the real industry is building around extracts. Over $118million worth of marijuana have already been sold in Colorado during the first quarter of 2015 and the market continues to grow month over month according to sales data. Green house growing is preferred when it comes to extracting the most resin from the cannabis plant and the trend to grow weed in greenhouses has come at a time that warehouse space is becoming more expensive and difficult to find. Since voters approved legalizing marijuana for recreational use in 2012, growers have absorbed more than 1 million square feet of industrial space, according to the industrial Market Trends report by Newmark Grubb Knight Frank. The total space occupied by the industry is more than 4 million square feet.

      Therefore, those who have already begun the arduous process of land use approval and conditional use permission will already have a leg up during somewhat of a paradigm shift from bud to extracts. As a liaison and consultant in this niche, CannaGrow can quickly gain market share necessary to carve out a leading position within the space.

      Buffalo Ranch

      Since initiating the submission process for approval of land use in Huerfano County, CannaGrow, acting as a facilitator and liaison, has been able to have approval granted for the project while also continuing its development of the new site. Keep in mind that Colorado may be known for a cooler climate, the state has 300 days of sunshine making it an ideal location for a green house project. Through a series of amendments and multiple meetings with the Huerfano County Planning Commission, both the Land Use Application and Conditional Use Permits were approved and signed which officially marked “the beginning.” This all came together at the end of May and will allow the commercial cultivation of Marijuana on Colorado Buffalo Ranch Filing No. 5-Lot 61, by a licensed Grower that is certified by the State.

      Phase II

      CGRW has been no stranger to price movement. The initial run up from $0.04 to $1.05 just a few months ago has triggered much more attention to be placed on the company and the current projects that it has under development. A much more solidified proof point for CGRW longs will come when the company releases its Phase I and Phase II results. The goal is to become the first large-scale commercial grow operation in Huerfano County Colorado and now that the proper documentation has been procured, the Company can now focus on sourcing materials and manpower for the build out.

      Phase V

      According to CannaGrow, “Phase I & II consists of site grading for the ingress & egress roadways, a 3200 sq. ft. head-works building, six 2300 sq. ft. hoop-houses for outdoor grows, an approximate 3,300 sq. ft. state-of-the-art Nexus Greenhouse that utilizes the most up to date technology for the growing of cannabis.”

      Phasing

      The full build-out of the grow facility will also include a 6,600 sq. ft. “Nexus Greenhouse”, the 3,200 sq. ft. “Olympia Steel Head-Works” building, and sixteen Hoop-houses. Everything from power to water supply has been accounted for and in order to obtain the CUP, the company made sure to bring on Terracon Consultants, Inc., an engineering company specializing in land development, environmental assistance & geotechnical services.

      At the moment, it would appear the company is optimistic about these next steps. In the most recent press release from May, the company stated, “The completion of this Project will provide CannaGrow the basis to begin generating revenues from the licensed Growers sub-leasing the Turnkey Growing Facilities being built to the specifications of CannaGrow consultants, Dr. John P. Janovec and Jason Wells. CannaGrow has already received numerous inquiries from perspective tenants and we are also exploring additional business ventures in the area that could further enhance shareholder value.”

      An analyst report written by BOTEC Analysis Corporation finds that indoor and outdoor grow operations yield roughly 40 grams per square foot of space. Multiple harvests per year would obviously increase this ratio. With the Buffalo Ranch facility, roughly 16,000 square feet of grow space would yield 640,000 grams or about 22,583 oz. At an average wholesale price of $2,000/lb, those ounces could hold more “weight” when it comes to the bottom line.

      The Trade

      Similar to the biotech space, which has been red hot this year, it’s my opinion that speculation and anticipation for the completion of this project could begin to fuel momentum in the market. The current price channel as identified above would suggest that there could be much more room between current price points and the 52-week high of $1.05 where CGRW could respond favorably to positive trading. This is especially in consideration of the recent consolidation the stock has seen as well.

      More news and continued corporate updates could be the catalyst for short bursts of momentum in the market during the near term. As far as the long-term outlook of this is concerned, results of Phase completion will be essential.

      Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

      We are your #1 source for all things Marijuana Stocks, Subscribe Below!

      Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
      Ad Placements